Abstract
Detection of Streptococcus thoraltensis in Raw Milk with Special Reference to Their Antibiogram
Highlights
The analyses in this report are based on data relating to diagnoses of pyogenic and nonpyogenic streptococcal bloodstream infections between 2011 and 2020 in England
2191 cases of GBS bacteraemia were reported by laboratories in England, an 11% increase since 2016
General declines in bacteraemia rates in 2020 compared to 2019 were seen for both pyogenic and non-pyogenic streptococcal species, with group A streptococcal (GAS) seeing the largest decline among pyogenic streptococci, and Mitis and Sanguinis groups seeing the largest decreases among the non-pyogenic streptococci
Summary
The analyses in this report are based on data relating to diagnoses of pyogenic and nonpyogenic streptococcal bloodstream infections between 2011 and 2020 in England. Records of group A streptococcal (GAS) bacteraemia based on isolates submitted to the UKHSA Antimicrobial Resistance and Hospital Associated Infections Reference Unit (AMRHAI, Colindale) were merged with laboratory reports (services have moved from the Respiratory and Vaccine Preventable Bacteria Reference Unit; RVPBRU). In England, laboratories are requested to submit data individually to SGSS, with reporting based on clinically significant isolates. A full list of the laboratory reported species assigned to each pyogenic and non-pyogenic group is available in the web appendix associated with this report. The report includes analyses on the trends, age and sex distribution, geographical distribution and antimicrobial susceptibility of laboratory-reported cases of pyogenic and non-pyogenic streptococcal bacteraemia. It should be noted that the data presented here for earlier years may differ from that in previous publications due to the inclusion of late reports
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have